CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Egis Gyogyszergyar Zrt is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Egis Gyogyszergyar Zrt
Kereszturi ut 30-38.
Phone: +36 18035555p:+36 18035555 BUDAPEST, 1106  Hungary Ticker: EGISEGIS

Business Summary
Egis Gyogyszergyar Zrt (EGIS) is a Hungary-based company engaged in the pharmaceutical industry. Its core activities are the production of pharmaceuticals and active pharmaceutical ingredients, research and development, sales of finished products and active pharmaceutical ingredients. Its product range includes tablets, ointments, suppositories, solutions, syrups and aerosols. EGIS is involved in research activities aimed at the development of generic pharmaceutical products. The operations are located in three production facilities, two in Budapest and one in Kormend of Hungary. As of December 31, 2012, the Company operated 10 wholly owned subsidiaries based in Hungary, Poland, Slovakia, the Czech Republic, Romania, Bulgaria, Turkey, the United Kingdom and the Russian Federation. The Company’s major shareholder was ATP (Servier), with a 50.91% stake in the capital.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
IRA CQ
Score
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-Yes----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
9/30/20139/30/2012Yes----

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Independent Chairman of the Board Jean-PhilippeSeta 1/29/1996 1/29/1996
Independent Chairman of the Supervisory Board AndorKovacs 12/31/1991 12/31/1991
Chief Executive Officer, Director IstvanHodasz 9/30/2009 1/16/2006
11 additional Officers and Directors records available in full report.

Business Names
Business Name
EGIS
Egis Gyogyszergyar NyRt.
Egis Gyogyszergyar Rt.
Egis Pharmaceuticals Limited

General Information
Number of Employees: 3,966 (As of 6/30/2013)
Outstanding Shares: 7,785,715 (As of 9/30/2013)
Shareholders: 1,269
Stock Exchange: BDP
Fax Number: +36 18035529


Copyright © 2020 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, March 28, 2020